A Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating

Simply Wall St.

Mar 01

Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2616821536"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616821536\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616821536?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-03-01 17:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616821536","market":"sg","top_or_hot":-1,"title":"A Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating","media":"Simply Wall St.","content":"<div>\n<p>Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-innv/innovage-holding/news/a-look-at-innovage-holding-innv-valuation-as-upward-earnings\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-01 17:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-innv/innovage-holding/news/a-look-at-innovage-holding-innv-valuation-as-upward-earnings><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-innv/innovage-holding/news/a-look-at-innovage-holding-innv-valuation-as-upward-earnings\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INNV","symbol_name":"InnovAge Holding Corp.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-innv/innovage-holding/news/a-look-at-innovage-holding-innv-valuation-as-upward-earnings","article_id":"2616821536","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-innv/innovage-holding/news/a-look-at-innovage-holding-innv-valuation-as-upward-earnings","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2616821536","pubTimestamp":1772356796,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock.\nSee our latest analysis for InnovAge Holding.\nThe recent upward revisions to earnings expectations come after a sharp run in the shares, with a 30 day share price return of 61.44% and a 1 year total shareholder return of 175.69%. This suggests momentum has recently picked up despite a weaker 5 year...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["rate","earning"],"viewcount":null,"language":"en","relate_stocks":{"INNV":"InnovAge Holding Corp."},"translate_title":"盈利上调推动强力买入评级，审视InnovAge Holding(INNV)估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INNV":1.5},"content_text":"Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock. See our latest analysis for InnovAge Holding. The recent upward revisions to earnings expectations come after a sharp run in the shares, with a 30 day share price return of 61.44% and a 1 year total shareholder return of 175.69%. This suggests momentum has recently picked up despite a weaker 5 year total shareholder return of 62.79%. If this kind of rapid repricing has your attention, it could be a good moment to see what else is moving and check out 27 healthcare AI stocks as potential next ideas to research. With the shares now at US$8.96 and trading above the average analyst price target of US$7.00, the key question is whether InnovAge is still trading at a discount or if the market is already factoring in future growth. AdvertisementMost Popular Narrative: 28% Overvalued Compared to the most followed narrative fair value of $7.00, InnovAge Holding’s last close at $8.96 sits well above that reference point. As a result, many investors are now asking how stretched the current pricing might be versus those assumptions.  Industry-wide healthcare policy is moving toward outcome-based and value-based care models, and InnovAge's integrated PACE model already aligns with these trends. This alignment is likely to support improved reimbursement rates and sustained margin growth. Enhancements in clinical management and care delivery, such as proactive preventive programs and in-home care, are reducing high-cost utilization (e.g., assisted living, skilled nursing). These changes are contributing to better medical expense control and improved earnings.  Read the complete narrative. Curious what kind of revenue path, margin profile, and valuation multiple have to line up to justify that $7.00 fair value? The narrative leans heavily on specific growth, profitability and discount rate assumptions that paint a very particular picture of InnovAge’s next few years. Result: Fair Value of $7.00 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to weigh rising care and compliance costs, along with ongoing de novo center losses. These factors could pressure margins and challenge this upbeat narrative. Find out about the key risks to this InnovAge Holding narrative. Another View: Cash Flows Tell a Different Story The narrative-based fair value of $7.00 paints InnovAge as 28% overvalued, but our DCF model points in the opposite direction. On that basis, the shares at $8.96 are trading at a 69.1% discount to an estimated future cash flow value of $28.96. That is a wide gap. Which lens do you trust more? Look into how the SWS DCF model arrives at its fair value. INNV Discounted Cash Flow as at Mar 2026Next Steps If this mix of optimism and concern feels hard to balance, do not wait for consensus. Instead, review the data yourself and weigh 3 key rewards and 2 important warning signs before you decide what it all adds up to. Looking for more investment ideas? If this story has sharpened your thinking, do not stop here. A few minutes with a focused screener could surface the next company worth a closer look.  Target long term compounding potential by checking companies that screen as 46 high quality undervalued stocks based on quality, cash flows, and pricing. Prioritize resilience and sleep better at night by filtering for 74 resilient stocks with low risk scores that keep overall risk scores in check. Get ahead of the crowd by scouting a screener containing 24 high quality undiscovered gems list where strong fundamentals have not yet attracted broad attention.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}